4 Amendments of Aldo PATRICIELLO related to 2019/2816(RSP)
Amendment 114 #
Paragraph 9
9. Points to the need to regulate pharmaceuticals under water legislation; recalls that interinstitutional negotiations are on-going on a review of the Directive on the quality of water intended for human consumption and on a regulation on minimum requirements for water reusake into account that specific pharmaceuticals are already regulated under the Water Framework Directive; recalls the importance of managing pharmaceuticals under the existing framework due to the public health role they serve;
Amendment 157 #
Paragraph 16
Amendment 166 #
Paragraph 16
16. Considers thatit inappropriate to include the environmental impacts of pharmaceuticals could be included into the benefit-risk assessment of human medicines, as is already the case for veterinary medicines; when it comes to ensuring that patients have access to safe and effective pharmaceutical treatments;
Amendment 231 #
Paragraph 32
32. Is concerned that monitoring of pharmaceuticals in the environment is still very limited; stresses the need to strengthen post-marketing control mechanisms into comprehensive monitoring, also with regard to environmental effects, as the current surveillance system (pharmacovigilance) is notand environmental monitoring, in order to ensure adequately and systematically covering scrutiny of the environmental data deficit;